Physician profile
Mikhail Silk
NPI 1508279944
$35,817.02
in general payments reported to CMS, 2019-2025
10 companies · $23K in 2025
The $23K reported for 2025 was more than what 94% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $173 · 2021: $130 · 2022: $139 · 2023: $3,223 · 2024: $9,126 · 2025: $23K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $27K · Travel and Lodging: $5,482 · Food and Beverage: $3,393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $26,500.00 |
| Travel and Lodging | $5,481.61 |
| Food and Beverage | $3,393.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Histosonics, INC. | $31,858.91 | 2024-2025 | |
| Boston Scientific Corporation | $2,520.32 | 2021-2024 | Ekosonic, Eluvia |
| Inari Medical, INC. | $680.89 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Angiodynamics, INC. | $250.97 | 2023 | Alphavac |
| Medtronic USA, INC. | $173.20 | 2019 | |
| Bard Peripheral Vascular, INC. | $110.98 | 2025 | Trek |
| Amgen INC. | $100.00 | 2023 | Repatha |
| Ge Healthcare | $80.00 | 2024 | |
| Stryker Corporation | $28.26 | 2025 | Flowtriever |
| Abbott Laboratories | $13.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mikhail Silk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.